As of Apr 28
| +0.02 / +0.39%|
The 7 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 15.00, with a high estimate of 33.00 and a low estimate of 10.00. The median estimate represents a +194.12% increase from the last price of 5.10.
The current consensus among 7 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.